An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

CINRYZE

STN: 125267
Proper Name: C1 Esterase Inhibitor (Human)
Tradename: CINRYZE
Manufacturer: ViroPharma Biologics LLC
Indication:

For routine prophylaxis against angioedema attacks in patients with Hereditary Angioedema (HAE).

Product Information

Package Insert - CINRYZE

Supporting Documents

April 1, 2022 Approval Letter - CINRYZE
June 20, 2018 Approval Letter - CINRYZE
June 20, 2018 Summary Basis for Regulatory Action - CINRYZE
Approval History, Letters, Reviews and Related Documents - CINRYZE
Supporting Documents older than three years - CINRYZE

Related Information

C1 Esterase Inhibitor

Top